Advertisement

Sjögren’s Syndrome

  • Troy Daniels

Abstract

  • Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease with early and gradually progressive lacrimal and salivary dysfunction.

  • Secondary SS occurs in association with other autoimmune disorders, the most common of which is rheumatoid arthritis.

  • Minor salivary glands and lacrimal glands in SS exhibit a particular pattern of periductal lymphocytic infiltration known as focal lymphocytic sialadenitis.

  • About 90% of patients with SS are women.

  • Sjögren’s syndrome is very common, with a community prevalence of pSS ranging from 0.1% to 0.6% of all individuals.

  • The major eye problem in SS is keratoconjunctivitis sicca, leading to xerophthalmia. The principal oral manifestation of SS is decreased salivary gland production, leading to xerostomia and a predilection for dental caries.

  • Extraglandular manifestations of SS include arthralgias, thyroiditis, renal involvement (leading to renal tubular acidosis), peripheral neuropathy, cutaneous vasculitis, and lymphoma.

  • The risk of lymphoma in pSS is approximately 5%.

  • Most patients with SS develop increased circulating polyclonal immunoglobulins and autoantibodies. These autoantibodies include two fairly specific antibodies directed against the Ro (SS-A) and La (SS-B) antigens.

  • ■ Anti-Ro and -La antibodies may be associated with fetal heart block during the pregnancies of women with SS.

Keywords

Salivary Gland Minor Salivary Gland Cutaneous Vasculitis Congenital Heart Block Oral Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bowman S, Ibrahim G, Holmes G, Hamburger J, Ainsworth J. Estimating the prevalence among Caucasian women of primary Sjögren’s syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004;33:39–43.PubMedCrossRefGoogle Scholar
  2. 2.
    Gottenberg J, Busson M, Loiseau P, et al. In primary Sjögren’s syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheumatol 2003;48:2240–2245.CrossRefGoogle Scholar
  3. 3.
    Triantafyllopoulou A, Tapinos N, Moutsopoulos H. Evidence for Coxsackievirus infection in primary Sjögren’s syndrome. Arthritis Rheumatol 2004;50:2897–2902.CrossRefGoogle Scholar
  4. 4.
    Ramos-Casals M, Loustaud-Ratti V, DeVita S, et al. Sjögren syndrome associated with hepatitis C virus. A multicenter analysis of 137 cases. Medicine 2005;84:81–89.PubMedCrossRefGoogle Scholar
  5. 5.
    Daniels T, Whitcher J. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren’s syndrome. Arthritis Rheumatol 1994;37:869–877.CrossRefGoogle Scholar
  6. 6.
    Larsson C, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren’s syndrome and healthy subjects. Scand J Immunol 2005;61:98–107.PubMedCrossRefGoogle Scholar
  7. 7.
    Prochorec-Sobieszek M, Wagner T, Loukas M, Chwaliska-Sadowska H, Olesiska M. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren’s syndrome. Med Sci Monit 2004;10:BR115–BR21.PubMedGoogle Scholar
  8. 8.
    Mitsias D, Tzioufas A, Veiopoulou C, et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren’s syndrome. Clin Exp Immunol 2002;128:562–568.PubMedCrossRefGoogle Scholar
  9. 9.
    Mariette X, Roux S, Zhang J, et al. The level of BlyS (BAFF) correlates with the titer of autoantibodies in human Sjögren’s syndrome. Ann Rheum Dis 2003;62:168–171.PubMedCrossRefGoogle Scholar
  10. 10.
    Li J, Ha Y, Ku N, et al. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren’s syndrome. Lab Invest 2004;84:1430–1438.PubMedCrossRefGoogle Scholar
  11. 11.
    Whitcher J, Gritz D, Daniels T. The dry eye: a diagnostic dilemma. Int Ophthalmal Clin 1998;38:23–37.CrossRefGoogle Scholar
  12. 12.
    Daniels T. Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 cases. Arthritis Rheumatol 1984;27:147–156.CrossRefGoogle Scholar
  13. 13.
    Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren’s syndrome. Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 2002;81:270–280.PubMedCrossRefGoogle Scholar
  14. 14.
    Matsumoto T, Morizane T, Aoki Y, et al. Autoimmune hepatitis in primary Sjögren’s syndrome: pathological study of the livers and labial salivary glands in 17 patients. Pathol Int 2005;55:70–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Ramos-Casals M, Anaya JM, Garcia-Carrasco M, et al. Cutaneous vasculitis in primary Sjögren’s syndrome. Classifi cation and clinical significance of 52 patients. Medicine 2004;83:96–106.PubMedCrossRefGoogle Scholar
  16. 16.
    Zintzaras E, Voulgarelis M, Moutsopoulos H. The risk of lymphoma development in autoimmune diseases. Arch Intern Med 2005;165:2337–2344.PubMedCrossRefGoogle Scholar
  17. 17.
    Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Primary Sjögren’s syndrome. Hematologic pattern of disease expression. Medicine 2002;81:281–292.PubMedCrossRefGoogle Scholar
  18. 18.
    Ramos-Casals M, Brito-Zern P, Yage J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren’s syndrome. Rheumatology 2005;44:89–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Sjögren’s Syndrome Foundation. And the survey says... The Moisture Seekers 2006;24:1–3.Google Scholar
  20. 20.
    Vitali C, Bombardieri S, Moutsopoulos H, et al. Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheumatol 1993;36:340–347.CrossRefGoogle Scholar
  21. 21.
    Fox R, Robinson C, Curd J, Kozin F, Howell F. Sjögren’s syndrome. Proposed criteria for classification. Arthritis Rheumatol 1986;29:577–585.CrossRefGoogle Scholar
  22. 22.
    Vitali C, Bombardieri, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:544–558.CrossRefGoogle Scholar
  23. 23.
    Dawson L, Caulfield V, Stanbury J, Field A, Christmas S, Smith P. Hydroxychloroquine therapy in patients with primary Sjogren’s syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology 2005;44:449–455.PubMedCrossRefGoogle Scholar
  24. 24.
    Theander E, Manthorpe R, Jacobsson TH. Mortality and causes of death in primary Sjögren’s syndrome. Arthritis Rheum 2004;50:1262–1269.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Troy Daniels
    • 1
  1. 1.Schools of Dentistry and MedicineUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations